20605

Arthrocentesis, aspiration and/or injection; intermediate joint (e.g., temporomandibular, acromioclavicular, sternoclavicular, elbow, wrist, ankle, olecranon bursa)

Arthrocentesis of an intermediate joint (e.g., temporomandibular, acromioclavicular, sternoclavicular, elbow, wrist, ankle, olecranon bursa) involves the aspiration of synovial fluid from the joint space and/or the injection of therapeutic substances into the joint or bursa. This procedure is performed for both diagnostic and therapeutic purposes. Diagnostic aspiration helps identify the cause of joint pain, swelling, or inflammation by analyzing the synovial fluid for infection, crystals (e.g., gout, pseudogout), blood, or inflammatory markers. Therapeutic injection aims to reduce pain and inflammation, or provide lubrication, by delivering medication (e.g., corticosteroids, hyaluronic acid) directly into the affected area. The procedure typically includes the administration of local anesthesia.

Clinical Indications

  • Diagnosis of acute monoarthritis or oligoarthritis to rule out septic arthritis, gout, pseudogout, or other inflammatory conditions.
  • Relief of pain and inflammation associated with inflammatory arthritis (e.g., rheumatoid arthritis, psoriatic arthritis) refractory to systemic therapy.
  • Management of osteoarthritis, particularly with effusion and pain.
  • Treatment of bursitis (e.g., olecranon bursitis).
  • Aspiration of joint effusions causing pain or limiting range of motion.
  • Injection of local anesthetics for diagnostic blocks or pain relief.
  • Management of synovitis.

Procedure Steps

  1. Patient positioning, skin preparation with an antiseptic solution (e.g., povidone-iodine, chlorhexidine), and sterile draping of the operative field.
  2. Local anesthetic (e.g., lidocaine) is injected into the skin and subcutaneous tissues around the joint or bursa.
  3. A needle of appropriate gauge and length is inserted into the joint space or bursa, often guided by anatomical landmarks or imaging (if medically necessary).
  4. If indicated, synovial fluid is aspirated using a syringe and sent for laboratory analysis (e.g., cell count with differential, Gram stain, culture, crystal analysis).
  5. If indicated, after aspiration (or as a standalone procedure), the therapeutic agent (e.g., corticosteroid, hyaluronic acid) is injected into the joint or bursa.
  6. The needle is withdrawn, pressure is applied to the site, and a sterile dressing is applied.
  7. Instructions given to the patient regarding activity restrictions, monitoring for complications, and follow-up.

Coding Guidelines

  • Code 20605 is reported once per joint or bursa injected/aspirated, regardless of the number of needle entries into that specific joint or bursa during the same encounter.
  • If separate intermediate joints (e.g., left wrist and right elbow) are injected/aspirated during the same encounter, report 20605 for each joint, typically with appropriate laterality modifiers (-RT, -LT) or modifier -59 for distinct procedural services.
  • The procedure includes local anesthesia and routine supplies. Separate reporting for these is not allowed.
  • If imaging guidance (e.g., ultrasound, fluoroscopy) is used and medically necessary, it should be reported separately using codes such as 76942 (ultrasound guidance for needle placement) or 77002 (fluoroscopic guidance for needle placement). Documentation must clearly support the medical necessity for guidance.
  • The therapeutic substance injected (e.g., corticosteroid, hyaluronic acid) is reported separately using appropriate HCPCS Level II codes (J-codes).
  • This procedure typically has a 0-day global period.
  • Medical record documentation must clearly specify the indication for the procedure, the specific joint(s) or bursa treated, substances injected (name, dose), any aspiration findings, complications, and post-procedure instructions.

Associated ICD-10 Codes